Aclaris Therapeutics, Inc. - Common Stock — 재무제표 (NASDAQ:ACRS) | MetaTrader

전체 차트 열기 Full chart

Financials

개요 성명 통계

총자산 70.78 M251.21 M254.6 M197.41 M220.33 M160.46 M 총 부채 33.13 M53.87 M56.98 M40.23 M64.77 M57.38 M 자본금 총액 37.65 M197.34 M197.62 M157.18 M155.55 M103.08 M 총 부채 및 주주자본 70.78 M251.21 M254.6 M197.41 M220.33 M160.46 M 총부채 —————— 순부채 ——————

뉴스

Aclaris Therapeutics (ACRS) Reports Q1 Loss, Beats Revenue Estimates

Rigel Pharmaceuticals (RIGL) Lags Q1 Earnings and Revenue Estimates

Aclaris Therapeutics, Inc. (ACRS) Discusses Clinical Program Update and Progress of Lead Bispecific Antibody Candidates - Slideshow (NASDAQ:ACRS) 2026-04-28

Profound Medical (PROF) Surges 13.0%: Is This an Indication of Further Gains?

아클라리스 테라퓨틱스, H.C. Wainwright ’매수’ 등급 재확인

Aclaris Therapeutics stock rating reiterated at Buy by H.C. Wainwright

스티펠, Aclaris Therapeutics 목표 주가 3달러로 상향

Stifel raises Aclaris Therapeutics stock price target to $3 on pipeline

Aclaris Therapeutics (ACRS) Reports Q4 Loss, Lags Revenue Estimates

Aclaris Therapeutics Inc Q4 실적, 수익 에상치보다 저조

Aclaris Therapeutics Inc earnings missed by $0.01, revenue fell short of estimates

Ionis Pharmaceuticals (IONS) Reports Q4 Loss, Tops Revenue Estimates